PharmaEssentia Corporation Share Price LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
20/10/2026
|
5-day change | 1st Jan Change | ||
| 35.40 USD | -2.21% |
|
-2.21% | +161.96% |
| Market Cap | 48TCr 1.47TCr 1.3TCr 1.21TCr 1.1TCr 2.06TCr 1,38800Cr 2.09TCr 15TCr 5.7TCr 73TCr 5.5TCr 5.38TCr 2,31800Cr | P/E 2026 * |
43x | P/E 2027 * | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 46TCr 1.39TCr 1.24TCr 1.15TCr 1.04TCr 1.96TCr 1,32100Cr 1.99TCr 14TCr 5.42TCr 69TCr 5.23TCr 5.12TCr 2,20600Cr | EV / Sales 2026 * |
16.7x | EV / Sales 2027 * | 10.7x |
| Free-Float |
79.23% | Yield 2026 * |
0.35% | Yield 2027 * | 0.2% |
| 1 day | -2.21% | ||
| 1 week | -2.21% | ||
| Current month | -7.33% | ||
| 1 month | -4.32% | ||
| 3 months | -2.75% | ||
| 6 months | +87.11% | ||
| Current year | +161.96% |
| 1 week | 35.4 |  | 38.4 |
| 1 month | 35.4 | | 38.4 |
| Current year | 14.05 | | 49.8 |
| 1 year | 13.06 | | 49.8 |
| 3 years | 8.55 | | 49.8 |
| 5 years | 7.97 | | 49.8 |
| 10 years | 7.97 | | 49.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2017 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Cheng Ku Huang
PSD | President | - | 25/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 09/05/2000 |
Ching-Leou Teng
CHM | Chairman | - | 24/09/2012 |
Cheng Ku Huang
BRD | Director/Board Member | - | 29/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.21% | -2.21% | - | - | 1.47TCr | |
| +0.79% | -6.16% | +49.32% | +74.50% | 6.63TCr | |
| +1.92% | +10.35% | +13.02% | +87.74% | 5.29TCr | |
| +6.91% | +8.57% | +6.88% | +72.12% | 5.48TCr | |
| +0.74% | +2.75% | +26.31% | +45.29% | 4.41TCr | |
| +3.87% | +10.15% | +20.69% | +132.73% | 4.37TCr | |
| +7.91% | +4.30% | +263.91% | +602.72% | 4.21TCr | |
| -0.40% | +9.85% | +17.04% | +59.17% | 3.4TCr | |
| -1.10% | -0.52% | +37.37% | +7.22% | 2.62TCr | |
| +2.36% | +5.34% | +30.98% | +26.07% | 2.34TCr | |
| Average | +2.08% | +1.67% | +51.72% | +123.06% | 4.31TCr | |
| Weighted average by Cap. | +2.60% | +1.99% | +51.10% | +127.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.72TCr 83Cr 74Cr 69Cr 62Cr 117.01Cr 7.89TCr 118.97Cr 824.43Cr 323.87Cr 4.13TCr 312.41Cr 305.93Cr 13TCr | 4.15TCr 126.96Cr 113.01Cr 104.74Cr 95Cr 178.37Cr 12TCr 181.35Cr 1.26TCr 493.71Cr 6.29TCr 476.24Cr 466.36Cr 20TCr |
| Net income | 1.08TCr 33Cr 30Cr 27Cr 25Cr 47Cr 3.14TCr 47Cr 328.5Cr 129.05Cr 1.65TCr 124.48Cr 121.9Cr 5.25TCr | 1.81TCr 56Cr 49Cr 46Cr 42Cr 78Cr 5.26TCr 79Cr 549.87Cr 216.01Cr 2.75TCr 208.37Cr 204.05Cr 8.79TCr |
| Net Debt | -2.3TCr -71Cr -63Cr -58Cr -53Cr -99Cr -6.68TCr -100.79Cr -698.48Cr -274.39Cr -3.5TCr -264.68Cr -259.19Cr -11TCr | -3.42TCr -104.83Cr -93Cr -86Cr -78Cr -147.28Cr -9.93TCr -149.75Cr -1.04TCr -407.66Cr -5.2TCr -393.23Cr -385.08Cr -17TCr |
| Date | Price | Change |
|---|---|---|
| 20/26/20 | $35.40 | -2.21% |
| 19/26/19 | $36.20 | -5.73% |
| 16/26/16 | $38.40 | +3.23% |
| 15/26/15 | $37.20 | +0.54% |
| 14/26/14 | $37.00 | +2.21% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280558 Stock
Select your edition
All financial news and data tailored to specific country editions
